{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T09:25:05Z","timestamp":1795166705508,"version":"4.10.3"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate the association between continuous glucose monitoring in pregnant people with type 2 diabetes and perinatal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This was a retrospective cohort study of pregnant people with type 2 diabetes who received prenatal care and delivered singleton, nonanomalous neonates at a single academic tertiary care center from November 1, 2019, to February 28, 2023. The primary outcome was a composite of neonatal morbidity, including hypoglycemia, hyperbilirubinemia, shoulder dystocia, large for gestational age at birth, preterm birth, neonatal intensive care unit (NICU) admission, or perinatal death. Demographics and outcomes were compared by type of monitoring (continuous glucose monitoring vs intermittent self-monitoring of blood glucose), and multivariable logistic regression estimated the association between continuous glucose monitoring use and perinatal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of 360 pregnant people who met the inclusion criteria, 82 (22.7%) used continuous glucose monitoring. The mean gestational age at continuous glucose monitoring initiation was 21.3\u00b16.4 weeks. The use of continuous glucose monitoring was associated with lower odds of the primary composite neonatal morbidity (65.9% continuous glucose monitoring vs 77.0% self-monitoring of blood glucose, adjusted odds ratio [aOR] 0.48, 95% CI, 0.24\u20130.94). Continuous glucose monitoring use was also associated with lower odds of preterm birth (13.4% vs 25.2%, aOR 0.48, 95% CI, 0.25\u20130.93) and NICU admission (33.8% vs 47.6%, aOR 0.36, 95% CI, 0.16\u20130.81).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>In pregnant people with type 2 diabetes, continuous glucose monitoring use was associated with less neonatal morbidity, fewer preterm births, and fewer NICU admissions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005609","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:00:50Z","timestamp":1716483650000},"page":"677-683","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Continuous Glucose Monitoring for Management of Type 2 Diabetes and Perinatal Outcomes"],"prefix":"10.1097","volume":"144","author":[{"given":"Charles E.","family":"Padgett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macie L.","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Fleenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki B.","family":"Orfanakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Battarbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"R1-20260826","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1097\/AOG.0000000000002960","article-title":"Pregestational diabetes mellitus. ACOG Practice Bulletin No. 201. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R2-20260826","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.15585\/mmwr.mm6743a2","article-title":"Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth\u2013United States, 2012-2016","volume":"67","author":"Deputy","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-20260826","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1001\/jama.2023.22949","article-title":"Metformin plus insulin for preexisting diabetes or gestational diabetes in early pregnancy the MOMPOD randomized clinical trial","volume":"330","author":"Boggess","year":"2023","journal-title":"JAMA"},{"key":"R4-20260826","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R5-20260826","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R6-20260826","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/dme.13585","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: benefits for mothers, using pumps or pens, and their babies","volume":"35","author":"Feig","year":"2018","journal-title":"Diabet Med"},{"key":"R7-20260826","doi-asserted-by":"crossref","first-page":"100969","DOI":"10.1016\/j.ajogmf.2023.100969","article-title":"Continuous glucose monitor use in type 2 diabetes mellitus in pregnancy and perinatal outcomes: a systematic review and meta-analysis","volume":"5","author":"Wilkie","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N Engl J Med"},{"key":"R9-20260826","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.2337\/dc24-S015","article-title":"15. Management of diabetes in pregnancy: Standards of Care in Diabetes\u20132024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"R10-20260826","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"R11-20260826","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ajog.2022.07.045","article-title":"Unified standard for fetal growth velocity: the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies","volume":"227","author":"Grantz","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20260826","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"key":"R13-20260826","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2337\/dc12-2360","article-title":"The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial","volume":"36","author":"Secher","year":"2013","journal-title":"Diabetes Care"},{"key":"R14-20260826","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/dom.13310","article-title":"Continuous Glucose Monitoring During Diabetic Pregnancy (GlucoMOMS): a multicentre randomized controlled trial","volume":"20","author":"Voormolen","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"R15-20260826","doi-asserted-by":"crossref","first-page":"a1680","DOI":"10.1136\/bmj.a1680","article-title":"Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial","volume":"337","author":"Murphy","year":"2008","journal-title":"BMJ"},{"key":"R16-20260826","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.2337\/dc24-S007","article-title":"7. Diabetes technology: standards of care in diabetes\u20132024","volume":"47","year":"2024","journal-title":"Diabetes Care"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:00:41Z","timestamp":1787742041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005609","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"2024-01-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}